The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 07, 2020

Filed:

Jun. 29, 2016
Applicants:

Nantbio, Inc., Culver City, CA (US);

Nantomics, Llc, Culver City, CA (US);

Nant Holdings Ip, Llc, Culver City, CA (US);

Inventors:

Shahrooz Rabizadeh, Culver City, CA (US);

Oleksandr Buzko, Los Angeles, CA (US);

Paul Weingarten, Anaheim, CA (US);

Heather McFarlane, Los Angeles, CA (US);

Connie Tsai, Culver City, CA (US);

Stephen Charles Benz, Santa Cruz, CA (US);

Kayvan Niazi, Culver City, CA (US);

Patrick Soon-Shiong, Culver City, CA (US);

Assignees:

NantBio, Inc., Culver City, CA (US);

NantOmics, LLC, Culver City, CA (US);

Nant Holdings IP, LLC, Culver City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4196 (2006.01); A61K 45/06 (2006.01); A61K 31/538 (2006.01); A61P 35/00 (2006.01); A61K 31/4155 (2006.01); A61K 31/4178 (2006.01); A61K 31/4439 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4196 (2013.01); A61K 31/4155 (2013.01); A61K 31/4178 (2013.01); A61K 31/4439 (2013.01); A61K 31/538 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01);
Abstract

Various compounds, compositions, and methods for inhibition of Rit1 are presented. In especially preferred aspects, contemplated compounds and compositions are suitable for treatment of cancers and other diseases associated with Rit1 signaling.


Find Patent Forward Citations

Loading…